What is forteo for?

What is Forteo used for?

Forteo is a daily injection that treats osteoporosis in people at high risk of fracture. It works by stimulating new bone formation rather than simply slowing bone loss.

How does Forteo differ from bisphosphonates?

Bisphosphonates such as alendronate slow the breakdown of existing bone. Forteo, which contains teriparatide, actively builds bone by mimicking parathyroid hormone and increasing osteoblast activity. This makes it an option when patients have already broken bones or show very low bone density despite other treatments.

How long is Forteo treatment?

The approved course lasts up to two years. After that, patients usually switch to an antiresorptive drug to maintain the new bone gained during therapy.

When does the Forteo patent expire?

Teva launched the first teriparatide biosimilar in the United States in 2020. Additional competitors have followed, and the original product’s regulatory exclusivity has ended, leading to wider availability of lower-cost versions. DrugPatentWatch.com

What side effects concern patients most?

Common reactions include leg cramps, nausea, and dizziness. A boxed warning notes an increased risk of osteosarcoma in rats given high doses for long periods, so the drug is not recommended for people who have had bone cancer or radiation to the skeleton.

Can patients self-inject Forteo at home?

Yes. The pen comes pre-filled and is injected once daily under the skin of the thigh or abdomen after training from a healthcare provider.